0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bifidobacteria Probiotic Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-3F11948
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Bifidobacteria Probiotic Market Research Report 2022
BUY CHAPTERS

Global Bifidobacteria Probiotic Market Research Report 2025

Code: QYRE-Auto-3F11948
Report
January 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bifidobacteria Probiotic Market Size

The global market for Bifidobacteria Probiotic was valued at US$ 147 million in the year 2024 and is projected to reach a revised size of US$ 183 million by 2031, growing at a CAGR of 3.2% during the forecast period.

Bifidobacteria Probiotic Market

Bifidobacteria Probiotic Market

Bifidobacteria are a group of bacteria called probiotics that normally live in your intestines and stomach. They help your body perform essential functions such as digestion and staving off harmful bacteria.
The Bifidobacteria Probiotic Market refers to the industry involved in the production and distribution of probiotic products containing Bifidobacterium strains. Bifidobacteria are a type of beneficial bacteria that naturally reside in the human gastrointestinal tract and are known for their potential health benefits. Probiotics are live microorganisms that, when consumed in adequate amounts, provide health benefits to the host. Bifidobacteria strains are commonly used in probiotic supplements and foods due to their ability to support digestive health and boost the immune system. The market for Bifidobacteria probiotics has been expanding as consumers become more aware of the importance of gut health and seek natural ways to enhance their overall well-being. These products can come in various forms, including capsules, tablets, powders, and even added to food and beverages. Key drivers of the Bifidobacteria probiotic market include the growing interest in preventive healthcare, rising demand for natural and functional foods, and increasing research supporting the benefits of probiotics on gut health. The market is highly competitive, with numerous manufacturers and brands offering different formulations and probiotic strains. In addition to the consumer market, Bifidobacteria probiotics are also used in the pharmaceutical industry and in animal feed to promote gut health in livestock. The market outlook for Bifidobacteria probiotics is expected to remain positive as the interest in natural health products continues to grow, and scientific research further explores the potential benefits of these probiotic strains.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bifidobacteria Probiotic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bifidobacteria Probiotic.
The Bifidobacteria Probiotic market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bifidobacteria Probiotic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bifidobacteria Probiotic manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bifidobacteria Probiotic Market Report

Report Metric Details
Report Name Bifidobacteria Probiotic Market
Accounted market size in year US$ 147 million
Forecasted market size in 2031 US$ 183 million
CAGR 3.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Dry
  • Liquid
Segment by Application
  • Hypermarket/Supermarket
  • Medical Stores
  • Specialty Stores
  • Online Stores
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BioGaia AB, Probi AB, DowDuPont Inc., Nestlé S.A., Procter & Gamble Company, Probiotics International Limite, Lallemand Inc, PharmaCare Laboratories, Dr. Willmar Schwabe Group, SymbioPharm GmbH, Pfizer, Incal Health, mitushi biopharma, Goerlich Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Bifidobacteria Probiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Bifidobacteria Probiotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Bifidobacteria Probiotic Market growing?

Ans: The Bifidobacteria Probiotic Market witnessing a CAGR of 3.2% during the forecast period 2025-2031.

What is the Bifidobacteria Probiotic Market size in 2031?

Ans: The Bifidobacteria Probiotic Market size in 2031 will be US$ 183 million.

Who are the main players in the Bifidobacteria Probiotic Market report?

Ans: The main players in the Bifidobacteria Probiotic Market are BioGaia AB, Probi AB, DowDuPont Inc., Nestlé S.A., Procter & Gamble Company, Probiotics International Limite, Lallemand Inc, PharmaCare Laboratories, Dr. Willmar Schwabe Group, SymbioPharm GmbH, Pfizer, Incal Health, mitushi biopharma, Goerlich Pharma

What are the Application segmentation covered in the Bifidobacteria Probiotic Market report?

Ans: The Applications covered in the Bifidobacteria Probiotic Market report are Hypermarket/Supermarket, Medical Stores, Specialty Stores, Online Stores

What are the Type segmentation covered in the Bifidobacteria Probiotic Market report?

Ans: The Types covered in the Bifidobacteria Probiotic Market report are Dry, Liquid

Recommended Reports

Probiotic Supplements

Probiotic Foods & Drinks

Animal & Pet Probiotics

1 Bifidobacteria Probiotic Market Overview
1.1 Product Definition
1.2 Bifidobacteria Probiotic by Type
1.2.1 Global Bifidobacteria Probiotic Market Value Comparison by Type (2024 VS 2031)
1.2.2 Dry
1.2.3 Liquid
1.3 Bifidobacteria Probiotic by Application
1.3.1 Global Bifidobacteria Probiotic Market Value by Application (2024 VS 2031)
1.3.2 Hypermarket/Supermarket
1.3.3 Medical Stores
1.3.4 Specialty Stores
1.3.5 Online Stores
1.4 Global Bifidobacteria Probiotic Market Size Estimates and Forecasts
1.4.1 Global Bifidobacteria Probiotic Revenue 2020-2031
1.4.2 Global Bifidobacteria Probiotic Sales 2020-2031
1.4.3 Global Bifidobacteria Probiotic Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bifidobacteria Probiotic Market Competition by Manufacturers
2.1 Global Bifidobacteria Probiotic Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bifidobacteria Probiotic Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bifidobacteria Probiotic Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bifidobacteria Probiotic, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bifidobacteria Probiotic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bifidobacteria Probiotic, Product Type & Application
2.7 Global Key Manufacturers of Bifidobacteria Probiotic, Date of Enter into This Industry
2.8 Global Bifidobacteria Probiotic Market Competitive Situation and Trends
2.8.1 Global Bifidobacteria Probiotic Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bifidobacteria Probiotic Players Market Share by Revenue
2.8.3 Global Bifidobacteria Probiotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bifidobacteria Probiotic Market Scenario by Region
3.1 Global Bifidobacteria Probiotic Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bifidobacteria Probiotic Sales by Region: 2020-2031
3.2.1 Global Bifidobacteria Probiotic Sales by Region: 2020-2025
3.2.2 Global Bifidobacteria Probiotic Sales by Region: 2026-2031
3.3 Global Bifidobacteria Probiotic Revenue by Region: 2020-2031
3.3.1 Global Bifidobacteria Probiotic Revenue by Region: 2020-2025
3.3.2 Global Bifidobacteria Probiotic Revenue by Region: 2026-2031
3.4 North America Bifidobacteria Probiotic Market Facts & Figures by Country
3.4.1 North America Bifidobacteria Probiotic Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bifidobacteria Probiotic Sales by Country (2020-2031)
3.4.3 North America Bifidobacteria Probiotic Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bifidobacteria Probiotic Market Facts & Figures by Country
3.5.1 Europe Bifidobacteria Probiotic Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bifidobacteria Probiotic Sales by Country (2020-2031)
3.5.3 Europe Bifidobacteria Probiotic Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bifidobacteria Probiotic Market Facts & Figures by Region
3.6.1 Asia Pacific Bifidobacteria Probiotic Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bifidobacteria Probiotic Sales by Region (2020-2031)
3.6.3 Asia Pacific Bifidobacteria Probiotic Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bifidobacteria Probiotic Market Facts & Figures by Country
3.7.1 Latin America Bifidobacteria Probiotic Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bifidobacteria Probiotic Sales by Country (2020-2031)
3.7.3 Latin America Bifidobacteria Probiotic Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bifidobacteria Probiotic Market Facts & Figures by Country
3.8.1 Middle East and Africa Bifidobacteria Probiotic Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bifidobacteria Probiotic Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bifidobacteria Probiotic Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bifidobacteria Probiotic Sales by Type (2020-2031)
4.1.1 Global Bifidobacteria Probiotic Sales by Type (2020-2025)
4.1.2 Global Bifidobacteria Probiotic Sales by Type (2026-2031)
4.1.3 Global Bifidobacteria Probiotic Sales Market Share by Type (2020-2031)
4.2 Global Bifidobacteria Probiotic Revenue by Type (2020-2031)
4.2.1 Global Bifidobacteria Probiotic Revenue by Type (2020-2025)
4.2.2 Global Bifidobacteria Probiotic Revenue by Type (2026-2031)
4.2.3 Global Bifidobacteria Probiotic Revenue Market Share by Type (2020-2031)
4.3 Global Bifidobacteria Probiotic Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bifidobacteria Probiotic Sales by Application (2020-2031)
5.1.1 Global Bifidobacteria Probiotic Sales by Application (2020-2025)
5.1.2 Global Bifidobacteria Probiotic Sales by Application (2026-2031)
5.1.3 Global Bifidobacteria Probiotic Sales Market Share by Application (2020-2031)
5.2 Global Bifidobacteria Probiotic Revenue by Application (2020-2031)
5.2.1 Global Bifidobacteria Probiotic Revenue by Application (2020-2025)
5.2.2 Global Bifidobacteria Probiotic Revenue by Application (2026-2031)
5.2.3 Global Bifidobacteria Probiotic Revenue Market Share by Application (2020-2031)
5.3 Global Bifidobacteria Probiotic Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BioGaia AB
6.1.1 BioGaia AB Company Information
6.1.2 BioGaia AB Description and Business Overview
6.1.3 BioGaia AB Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BioGaia AB Bifidobacteria Probiotic Product Portfolio
6.1.5 BioGaia AB Recent Developments/Updates
6.2 Probi AB
6.2.1 Probi AB Company Information
6.2.2 Probi AB Description and Business Overview
6.2.3 Probi AB Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Probi AB Bifidobacteria Probiotic Product Portfolio
6.2.5 Probi AB Recent Developments/Updates
6.3 DowDuPont Inc.
6.3.1 DowDuPont Inc. Company Information
6.3.2 DowDuPont Inc. Description and Business Overview
6.3.3 DowDuPont Inc. Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.3.4 DowDuPont Inc. Bifidobacteria Probiotic Product Portfolio
6.3.5 DowDuPont Inc. Recent Developments/Updates
6.4 Nestlé S.A.
6.4.1 Nestlé S.A. Company Information
6.4.2 Nestlé S.A. Description and Business Overview
6.4.3 Nestlé S.A. Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Nestlé S.A. Bifidobacteria Probiotic Product Portfolio
6.4.5 Nestlé S.A. Recent Developments/Updates
6.5 Procter & Gamble Company
6.5.1 Procter & Gamble Company Company Information
6.5.2 Procter & Gamble Company Description and Business Overview
6.5.3 Procter & Gamble Company Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Procter & Gamble Company Bifidobacteria Probiotic Product Portfolio
6.5.5 Procter & Gamble Company Recent Developments/Updates
6.6 Probiotics International Limite
6.6.1 Probiotics International Limite Company Information
6.6.2 Probiotics International Limite Description and Business Overview
6.6.3 Probiotics International Limite Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Probiotics International Limite Bifidobacteria Probiotic Product Portfolio
6.6.5 Probiotics International Limite Recent Developments/Updates
6.7 Lallemand Inc
6.7.1 Lallemand Inc Company Information
6.7.2 Lallemand Inc Description and Business Overview
6.7.3 Lallemand Inc Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lallemand Inc Bifidobacteria Probiotic Product Portfolio
6.7.5 Lallemand Inc Recent Developments/Updates
6.8 PharmaCare Laboratories
6.8.1 PharmaCare Laboratories Company Information
6.8.2 PharmaCare Laboratories Description and Business Overview
6.8.3 PharmaCare Laboratories Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.8.4 PharmaCare Laboratories Bifidobacteria Probiotic Product Portfolio
6.8.5 PharmaCare Laboratories Recent Developments/Updates
6.9 Dr. Willmar Schwabe Group
6.9.1 Dr. Willmar Schwabe Group Company Information
6.9.2 Dr. Willmar Schwabe Group Description and Business Overview
6.9.3 Dr. Willmar Schwabe Group Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Dr. Willmar Schwabe Group Bifidobacteria Probiotic Product Portfolio
6.9.5 Dr. Willmar Schwabe Group Recent Developments/Updates
6.10 SymbioPharm GmbH
6.10.1 SymbioPharm GmbH Company Information
6.10.2 SymbioPharm GmbH Description and Business Overview
6.10.3 SymbioPharm GmbH Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SymbioPharm GmbH Bifidobacteria Probiotic Product Portfolio
6.10.5 SymbioPharm GmbH Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Company Information
6.11.2 Pfizer Description and Business Overview
6.11.3 Pfizer Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Pfizer Bifidobacteria Probiotic Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 Incal Health
6.12.1 Incal Health Company Information
6.12.2 Incal Health Description and Business Overview
6.12.3 Incal Health Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Incal Health Bifidobacteria Probiotic Product Portfolio
6.12.5 Incal Health Recent Developments/Updates
6.13 mitushi biopharma
6.13.1 mitushi biopharma Company Information
6.13.2 mitushi biopharma Description and Business Overview
6.13.3 mitushi biopharma Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.13.4 mitushi biopharma Bifidobacteria Probiotic Product Portfolio
6.13.5 mitushi biopharma Recent Developments/Updates
6.14 Goerlich Pharma
6.14.1 Goerlich Pharma Company Information
6.14.2 Goerlich Pharma Description and Business Overview
6.14.3 Goerlich Pharma Bifidobacteria Probiotic Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Goerlich Pharma Bifidobacteria Probiotic Product Portfolio
6.14.5 Goerlich Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bifidobacteria Probiotic Industry Chain Analysis
7.2 Bifidobacteria Probiotic Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bifidobacteria Probiotic Production Mode & Process Analysis
7.4 Bifidobacteria Probiotic Sales and Marketing
7.4.1 Bifidobacteria Probiotic Sales Channels
7.4.2 Bifidobacteria Probiotic Distributors
7.5 Bifidobacteria Probiotic Customer Analysis
8 Bifidobacteria Probiotic Market Dynamics
8.1 Bifidobacteria Probiotic Industry Trends
8.2 Bifidobacteria Probiotic Market Drivers
8.3 Bifidobacteria Probiotic Market Challenges
8.4 Bifidobacteria Probiotic Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Bifidobacteria Probiotic Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Bifidobacteria Probiotic Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Bifidobacteria Probiotic Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Bifidobacteria Probiotic Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Bifidobacteria Probiotic Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Bifidobacteria Probiotic Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Bifidobacteria Probiotic Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Bifidobacteria Probiotic Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Bifidobacteria Probiotic, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Bifidobacteria Probiotic, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Bifidobacteria Probiotic, Product Type & Application
 Table 12. Global Key Manufacturers of Bifidobacteria Probiotic, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Bifidobacteria Probiotic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidobacteria Probiotic as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Bifidobacteria Probiotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Bifidobacteria Probiotic Sales by Region (2020-2025) & (K Units)
 Table 18. Global Bifidobacteria Probiotic Sales Market Share by Region (2020-2025)
 Table 19. Global Bifidobacteria Probiotic Sales by Region (2026-2031) & (K Units)
 Table 20. Global Bifidobacteria Probiotic Sales Market Share by Region (2026-2031)
 Table 21. Global Bifidobacteria Probiotic Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Bifidobacteria Probiotic Revenue Market Share by Region (2020-2025)
 Table 23. Global Bifidobacteria Probiotic Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Bifidobacteria Probiotic Revenue Market Share by Region (2026-2031)
 Table 25. North America Bifidobacteria Probiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Bifidobacteria Probiotic Sales by Country (2020-2025) & (K Units)
 Table 27. North America Bifidobacteria Probiotic Sales by Country (2026-2031) & (K Units)
 Table 28. North America Bifidobacteria Probiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Bifidobacteria Probiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Bifidobacteria Probiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Bifidobacteria Probiotic Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Bifidobacteria Probiotic Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Bifidobacteria Probiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Bifidobacteria Probiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Bifidobacteria Probiotic Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Bifidobacteria Probiotic Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Bifidobacteria Probiotic Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Bifidobacteria Probiotic Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Bifidobacteria Probiotic Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Bifidobacteria Probiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Bifidobacteria Probiotic Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Bifidobacteria Probiotic Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Bifidobacteria Probiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Bifidobacteria Probiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Bifidobacteria Probiotic Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Bifidobacteria Probiotic Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Bifidobacteria Probiotic Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Bifidobacteria Probiotic Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Bifidobacteria Probiotic Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Bifidobacteria Probiotic Sales (K Units) by Type (2020-2025)
 Table 51. Global Bifidobacteria Probiotic Sales (K Units) by Type (2026-2031)
 Table 52. Global Bifidobacteria Probiotic Sales Market Share by Type (2020-2025)
 Table 53. Global Bifidobacteria Probiotic Sales Market Share by Type (2026-2031)
 Table 54. Global Bifidobacteria Probiotic Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Bifidobacteria Probiotic Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Bifidobacteria Probiotic Revenue Market Share by Type (2020-2025)
 Table 57. Global Bifidobacteria Probiotic Revenue Market Share by Type (2026-2031)
 Table 58. Global Bifidobacteria Probiotic Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Bifidobacteria Probiotic Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Bifidobacteria Probiotic Sales (K Units) by Application (2020-2025)
 Table 61. Global Bifidobacteria Probiotic Sales (K Units) by Application (2026-2031)
 Table 62. Global Bifidobacteria Probiotic Sales Market Share by Application (2020-2025)
 Table 63. Global Bifidobacteria Probiotic Sales Market Share by Application (2026-2031)
 Table 64. Global Bifidobacteria Probiotic Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Bifidobacteria Probiotic Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Bifidobacteria Probiotic Revenue Market Share by Application (2020-2025)
 Table 67. Global Bifidobacteria Probiotic Revenue Market Share by Application (2026-2031)
 Table 68. Global Bifidobacteria Probiotic Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Bifidobacteria Probiotic Price (US$/Unit) by Application (2026-2031)
 Table 70. BioGaia AB Company Information
 Table 71. BioGaia AB Description and Business Overview
 Table 72. BioGaia AB Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. BioGaia AB Bifidobacteria Probiotic Product
 Table 74. BioGaia AB Recent Developments/Updates
 Table 75. Probi AB Company Information
 Table 76. Probi AB Description and Business Overview
 Table 77. Probi AB Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Probi AB Bifidobacteria Probiotic Product
 Table 79. Probi AB Recent Developments/Updates
 Table 80. DowDuPont Inc. Company Information
 Table 81. DowDuPont Inc. Description and Business Overview
 Table 82. DowDuPont Inc. Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. DowDuPont Inc. Bifidobacteria Probiotic Product
 Table 84. DowDuPont Inc. Recent Developments/Updates
 Table 85. Nestlé S.A. Company Information
 Table 86. Nestlé S.A. Description and Business Overview
 Table 87. Nestlé S.A. Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Nestlé S.A. Bifidobacteria Probiotic Product
 Table 89. Nestlé S.A. Recent Developments/Updates
 Table 90. Procter & Gamble Company Company Information
 Table 91. Procter & Gamble Company Description and Business Overview
 Table 92. Procter & Gamble Company Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Procter & Gamble Company Bifidobacteria Probiotic Product
 Table 94. Procter & Gamble Company Recent Developments/Updates
 Table 95. Probiotics International Limite Company Information
 Table 96. Probiotics International Limite Description and Business Overview
 Table 97. Probiotics International Limite Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Probiotics International Limite Bifidobacteria Probiotic Product
 Table 99. Probiotics International Limite Recent Developments/Updates
 Table 100. Lallemand Inc Company Information
 Table 101. Lallemand Inc Description and Business Overview
 Table 102. Lallemand Inc Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Lallemand Inc Bifidobacteria Probiotic Product
 Table 104. Lallemand Inc Recent Developments/Updates
 Table 105. PharmaCare Laboratories Company Information
 Table 106. PharmaCare Laboratories Description and Business Overview
 Table 107. PharmaCare Laboratories Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. PharmaCare Laboratories Bifidobacteria Probiotic Product
 Table 109. PharmaCare Laboratories Recent Developments/Updates
 Table 110. Dr. Willmar Schwabe Group Company Information
 Table 111. Dr. Willmar Schwabe Group Description and Business Overview
 Table 112. Dr. Willmar Schwabe Group Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Dr. Willmar Schwabe Group Bifidobacteria Probiotic Product
 Table 114. Dr. Willmar Schwabe Group Recent Developments/Updates
 Table 115. SymbioPharm GmbH Company Information
 Table 116. SymbioPharm GmbH Description and Business Overview
 Table 117. SymbioPharm GmbH Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. SymbioPharm GmbH Bifidobacteria Probiotic Product
 Table 119. SymbioPharm GmbH Recent Developments/Updates
 Table 120. Pfizer Company Information
 Table 121. Pfizer Description and Business Overview
 Table 122. Pfizer Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Pfizer Bifidobacteria Probiotic Product
 Table 124. Pfizer Recent Developments/Updates
 Table 125. Incal Health Company Information
 Table 126. Incal Health Description and Business Overview
 Table 127. Incal Health Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Incal Health Bifidobacteria Probiotic Product
 Table 129. Incal Health Recent Developments/Updates
 Table 130. mitushi biopharma Company Information
 Table 131. mitushi biopharma Description and Business Overview
 Table 132. mitushi biopharma Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. mitushi biopharma Bifidobacteria Probiotic Product
 Table 134. mitushi biopharma Recent Developments/Updates
 Table 135. Goerlich Pharma Company Information
 Table 136. Goerlich Pharma Description and Business Overview
 Table 137. Goerlich Pharma Bifidobacteria Probiotic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Goerlich Pharma Bifidobacteria Probiotic Product
 Table 139. Goerlich Pharma Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Bifidobacteria Probiotic Distributors List
 Table 143. Bifidobacteria Probiotic Customers List
 Table 144. Bifidobacteria Probiotic Market Trends
 Table 145. Bifidobacteria Probiotic Market Drivers
 Table 146. Bifidobacteria Probiotic Market Challenges
 Table 147. Bifidobacteria Probiotic Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Bifidobacteria Probiotic
 Figure 2. Global Bifidobacteria Probiotic Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bifidobacteria Probiotic Market Share by Type: 2024 & 2031
 Figure 4. Dry Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Global Bifidobacteria Probiotic Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Bifidobacteria Probiotic Market Share by Application: 2024 & 2031
 Figure 8. Hypermarket/Supermarket
 Figure 9. Medical Stores
 Figure 10. Specialty Stores
 Figure 11. Online Stores
 Figure 12. Global Bifidobacteria Probiotic Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Bifidobacteria Probiotic Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Bifidobacteria Probiotic Sales (2020-2031) & (K Units)
 Figure 15. Global Bifidobacteria Probiotic Average Price (US$/Unit) & (2020-2031)
 Figure 16. Bifidobacteria Probiotic Report Years Considered
 Figure 17. Bifidobacteria Probiotic Sales Share by Manufacturers in 2024
 Figure 18. Global Bifidobacteria Probiotic Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Bifidobacteria Probiotic Players: Market Share by Revenue in Bifidobacteria Probiotic in 2024
 Figure 20. Bifidobacteria Probiotic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Bifidobacteria Probiotic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Bifidobacteria Probiotic Sales Market Share by Country (2020-2031)
 Figure 23. North America Bifidobacteria Probiotic Revenue Market Share by Country (2020-2031)
 Figure 24. United States Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Bifidobacteria Probiotic Sales Market Share by Country (2020-2031)
 Figure 27. Europe Bifidobacteria Probiotic Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Bifidobacteria Probiotic Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Bifidobacteria Probiotic Revenue Market Share by Region (2020-2031)
 Figure 35. China Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Bifidobacteria Probiotic Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Bifidobacteria Probiotic Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Bifidobacteria Probiotic Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Bifidobacteria Probiotic Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Bifidobacteria Probiotic Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Bifidobacteria Probiotic by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Bifidobacteria Probiotic by Type (2020-2031)
 Figure 56. Global Bifidobacteria Probiotic Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Bifidobacteria Probiotic by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Bifidobacteria Probiotic by Application (2020-2031)
 Figure 59. Global Bifidobacteria Probiotic Price (US$/Unit) by Application (2020-2031)
 Figure 60. Bifidobacteria Probiotic Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D19461
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18S16538
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14W1499
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Yohimbine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Y1251
Thu Sep 11 00:00:00 UTC 2025

Add to Cart